Big Pharma lobbies Australia to extend poppy growing

GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) and TPI Enterprises want the government of Australia to let them grow poppies on the country's mainland, due to a shortage of opium for pain killers and amid soaring demand.

Australia only allows poppy growing in Tasmania, which is responsible for around half of the world's supply of opiate-based pain relief. Recent drought and storms in Tasmania have meant that drug firms can't get enough crops.

From other sites
Comments (4)
  • Van Hyder
    , contributor
    Comments (172) | Send Message
    Can't get enough crop, that's going to hurt.
    11 Mar 2014, 09:26 AM Reply Like
  • pmiller100
    , contributor
    Comments (358) | Send Message
    The U.S. military is destroying poppy fields in Afghanistan. Maybe they ought to harvest instead of burn. They could funnel the product to big pharma, who presumably won't make it into Heroin, and return some proceeds to the local farmers who might appreciate something rather than just a scorched field.
    11 Mar 2014, 09:30 AM Reply Like
  • jumpnjoey77
    , contributor
    Comments (1222) | Send Message
    The Afghan stuff is more potent too.
    11 Mar 2014, 09:37 AM Reply Like
  • pmiller100
    , contributor
    Comments (358) | Send Message
    And you know that how exactly? Lol, just kidding.
    12 Mar 2014, 08:12 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs